Selecta Biosciences approves retention bonuses for five executives

Cartesian Therapeutics, Inc.

Carsten Brunn (CEO) and Blaine Davis each receive 2x annual salary bonus; Peter Traber 1.5x; Takashi Kei Kishimoto 1x; Lloyd Johnston 2x.
Bonus payable on first payroll after March 31, 2024 if executive remains employed in good standing.
Compensation Committee may accelerate payment or waive service requirements at its discretion.
Retention bonuses aim to incentivize key leadership continuity through March 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.